Recombinant human γ‐interferon in patients with chronic active hepatitis B: Pharmacokinetics, tolerance and biological effects
Patrick Marcellin, Marie‐Anne Loriot, Nathalie Boyer, Michéle Martinot‐Peignoux, Claude Degott, Françoise Degos, Maud Brandely, Bernard Lenfant, Jean‐Pierre Benhamou – 1 July 1990 – Pharmacokinetics, tolerance and biological effects of human recombinant γ‐interferon were studied in 12 patients with chronic active hepatitis B.